Carvedilol clinical trials
Also written Coreg.
Includes 11 studies of Carvedilol phosphate hydrate.
How each study uses Carvedilol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Carvedilol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Sept 1995 · COREG · NDA 020297 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
148 studies that test it; most in 2007 (13)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 13 |
| 2008 | 7 |
| 2009 | 2 |
| 2010 | 8 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 29 · Other 120
Institute of Liver and Biliary Sciences, India (9) · GlaxoSmithKline (8) · Chong Kun Dang Pharmaceutical (4) · University of Minnesota (3) · King's College Hospital NHS Trust (2) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2) · VA Office of Research and Development (2)
Often tested with
Tested in the same studies.
Metoprolol (13) · Carvedilol Phosphate Extended-Release Capsule (9) · Bisoprolol (6) · Nebivolol (6) · Lisinopril (6) · Valsartan (4) · Propranolol (4) · Empagliflozin (3)
Related medicines
As reviewed, each with the page that says it.
- One of Beta blockers source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Carvedilol is the comparator. A study of two new drugs counts under both.
- 1Alverine · Shanghai Changzheng Hospital
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test Carvedilol, phase 3 first.
- Dec 2026CSP #2026 - Beta Blocker Dialyzability on Cardiovascular OutcomesPhase 3 · VA Office of Research and Development
- Dec 2026Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.Phase 4 · King's College Hospital NHS Trust
- Dec 2026Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in CirrhosisNot applicable · Institute of Liver and Biliary Sciences, India
- May 2027Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline TherapyPhase 4 · Hospital Sirio-Libanes
Studies
Open first, then newest update. How each study uses Carvedilol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 149
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityRecruitingPhase 3SWOG Cancer Research NetworkNCT03418961Written as CarvedilolHow we know
- Non-selective Beta-blocker in Compensated Advanced Chronic Liver DiseaseRecruitingPhase 4Chinese University of Hong KongNCT06449339Written as CarvedilolHow we know
- CSP #2026 - Beta Blocker Dialyzability on Cardiovascular OutcomesRecruitingPhase 3VA Office of Research and DevelopmentNCT05931276Written as CarvedilolHow we know
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/ValsartanRecruitingPhase 1/2Virginia Commonwealth UniversityNCT05194111Written as CarvedilolHow we know
- DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With CirrhosisRecruitingPhase 4Post Graduate Institute of Medical Education and Research, ChandigarhNCT07322237Written as Empagliflozin + CarvedilolHow we know
- Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic VaricesEnrolling by invitationPhase 4Xijing HospitalNCT07352228Written as CarvedilolHow we know
- CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic UltrasoundRecruitingNot applicableUniversity Hospital, Clermont-FerrandNCT06861075Written as CarvedilolHow we know
- Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorRecruitingPhase 4University of RochesterNCT06964464Written as CarvedilolHow we know
- Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in CirrhosisRecruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01212250Written as carvedilolHow we know
- Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain InjuryRecruitingPhase 1/2Mansoura UniversityNCT06836856Written as CarvedilolHow we know
- Cardioprotection on Chemotherapy-Induced CardiotoxicityRecruitingPhase 3Ain Shams UniversityNCT06853951Written as β -BlockersHow we know
- Carvedilol and Alverine in Portal HypertensionNot yet recruitingPhase 2/3Shanghai Changzheng HospitalNCT06696248Written as Carvedilol and alverineHow we know
- Clinical Study Evaluating the Effect of Carvedilol in Patients With Active Rheumatoid ArthritisNot yet recruitingEarly Phase 1Tanta UniversityNCT06108518Written as CarvedilolHow we know
- Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced CardiomyopathyNot yet recruitingPhase 1Arab Contractors Medical CentreNCT06304896Written as CarvedilolHow we know
- Determination of Drug Levels for Pharmacotherapy of Heart FailureNot yet recruitingPhase 4University Hospital OstravaNCT06035978Written as CarvedilolHow we know
- Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal BleedingRecruitingPhase 2/3Sherief Abd-ElsalamNCT04499898Written as CarvedilolHow we know
- Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline TherapyActive, not recruitingPhase 4Hospital Sirio-LibanesNCT04939883Written as CarvedilolHow we know
- Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureTerminatedPhase 2Mayo ClinicNCT03879629Written as CarvedilolHow we know
- Carvedilol in HF With Preserved EFCompletedPhase 4Seoul National University Bundang HospitalNCT05553314Written as CarvedilolHow we know
- HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed TherapyTerminatedPhase 2Washington University School of MedicineNCT06844669Written as CarvedilolHow we know
See all 149 studies that test Carvedilol →
Given beside what is tested · 12 — Carvedilol is usual care or a partner of the new treatment
- Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and SurvivalRecruitingNot applicablePost Graduate Institute of Medical Education and Research, ChandigarhNCT06431919Written as Carvedilol 3.125 mgHow we know
- Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis BNot yet recruitingNot applicableBeijing 302 HospitalNCT07809165Written as Nucleos(t)ide AnaloguesHow we know
- Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisRecruitingPhase 4Asian Institute Of Medical SciencesNCT07521332Written as CarvedilolHow we know
- Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.Not yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT07465471Written as CarvedilolHow we know
- Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.RecruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT07108075Written as CarvedilolHow we know
- Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal VaricesNot yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06836778Written as Carvedilol TabletsHow we know
- Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior DecompensationNot yet recruitingNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT06041932Written as CarvedilolHow we know
- Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialWithdrawnPhase 2Mayo ClinicNCT04190433Written as CarvedilolHow we know
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownPhase 3Tianjin Second People's HospitalNCT04543643Written as CarvedilolHow we know
- Carvedilol + VSL#3 Versus Endoscopic Variceal Ligation for Primary Prophylaxis of Esophageal Variceal Bleeding in Cirrhotic Patients Non Responder to Carvedilol.CompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01196481Written as Carvedilol+VSL#3How we know
- HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic PatientsStatus unknownNot applicableAir Force Military Medical University, ChinaNCT04254822Written as CarvedilolHow we know
- The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric VaricesStatus unknownPhase 4Shanghai Zhongshan HospitalNCT02638415Written as CarvedilolHow we know
As the comparator · 11 — what is tested is compared with Carvedilol
- The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver CirrhosisNot yet recruitingPhase 2/3Shanghai Changzheng HospitalNCT06470386Written as CarvedilolHow we know
- LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)CompletedPhase 4Organon and CoNCT00496834Written as Comparator: carvedilolHow we know
- Banding Ligation With Carvedilol Versus Carvedilol for the Prevention of First BleedingTerminatedPhase 4E-DA HospitalNCT01383044Written as carvedilolHow we know
- Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure PatientsStatus unknownNot applicableDong-A UniversityNCT02619526Written as CarvedilolHow we know
- Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.WithdrawnNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT01659346Written as CarvedilolHow we know
- Immediate Release Versus Slow Release Carvedilol in Heart FailureStatus unknownPhase 4Seoul National University Bundang HospitalNCT03209180Written as Carvedilol IR (Immediate Release)How we know
- Carvedilol for Psychostimulant DependenceCompletedPhase 2University of ArkansasNCT01171183Written as controlled release carvedilolHow we know
- Heart Rate Reduction in Heart FailureCompletedPhase 3IRCCS San RaffaeleNCT01178528Written as CarvedilolHow we know
- Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting ConditionCompletedPhase 1IPCA Laboratories Ltd.NCT01577914Written as CarvedilolHow we know
- Ischemia In Hemodialysed Patients: Ivabradine Versus CarvedilolStatus unknownPhase 4University of Campania Luigi VanvitelliNCT01425164Written as CarvedilolHow we know
- Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With HypertensionStatus unknownPhase 3Ahn-Gook Pharmaceuticals Co.,LtdNCT01413048Written as Carvedilol 25mgHow we know
Codes
What other systems call Carvedilol · ClinicalTrials.gg INT006677
- MeSH (NLM) D000077261CarvedilolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0K47UL67F2CARVEDILOLConfirmed FDA, NLM, Wikidata
- UNII (FDA) GW13D96INDCARVEDILOL, (-)-Confirmed NLM, Wikidata
- UNII (FDA) N6E193E020CARVEDILOL, (+)-Confirmed NLM, Wikidata
- RxNorm 20352Confirmed FDA, Wikidata
- Wikidata Q412534carvedilolConfirmed FDA, NLM, Wikidata
- Wikidata Q27279308(-)-carvedilolConfirmed NLM, Wikidata
- Wikidata Q27284614(+)-carvedilolConfirmed NLM, Wikidata
- NCI Thesaurus C28906CarvedilolOne source FDA
- DrugBank DB01136One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077261 | Carvedilol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0K47UL67F2 | CARVEDILOL | Confirmed FDA, NLM, Wikidata |
| UNII (FDA) | GW13D96IND | CARVEDILOL, (-)- | Confirmed NLM, Wikidata |
| UNII (FDA) | N6E193E020 | CARVEDILOL, (+)- | Confirmed NLM, Wikidata |
| RxNorm | 20352 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412534 | carvedilol | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27279308 | (-)-carvedilol | Confirmed NLM, Wikidata |
| Wikidata | Q27284614 | (+)-carvedilol | Confirmed NLM, Wikidata |
| NCI Thesaurus | C28906 | Carvedilol | One source FDA |
| DrugBank | DB01136 | — | One source Wikidata |
Also registered as carvedilol hydrochloride (UNII N9A00DJ8CM).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.